Title of article
Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder
Author/Authors
Sajatovic، نويسنده , , Martha and Jenkins، نويسنده , , Janis H. and Cassidy، نويسنده , , Kristin A. and Muzina، نويسنده , , David J.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2009
Pages
7
From page
360
To page
366
Abstract
Background
tive experience of illness affects outcomes among populations with bipolar disorder (BD). This cross-sectional study combined qualitative and quantitative approaches to evaluate perceived treatment effects, concerns and expectations among 90 individuals with BD.
s
with Type I BD, mean age 36.6 years, 51% women, completed a semi-structured interview that was audio taped, transcribed, coded and analyzed along emergent themes. Quantitative scales measured depressive symptoms (Hamilton Depression Scale/HAM-D), psychopathology (Clinical Global Impression/CGI), and insight and treatment attitudes (Insight and Treatment Attitudes Questionnaire/ITAQ).
s
duals had moderate depression and psychopathology with good insight into need for treatment. Drug treatment was perceived as beneficial, by “stabilizing” or “balancing” mood (42%, N = 38), decreasing anxiety/depressive symptoms (19%, N = 17) and improving sleep (10%, N = 9). While 39%, (N = 35) of individuals denied medication concerns, nearly 29%, (N = 26) feared possible long-term effects, particularly diabetes or liver/kidney damage. Media stories and advertisements contributed to medication fears. Hopes and expectations for treatment ranged from those that were symptom or functional status-based, such as desiring mood stabilization and elimination of specific symptoms (23%, N = 21), to more global hopes such as “being normal” (20%, N = 18) or “cured” (18%, N = 16).
tions
tions include relatively small sample, lack of a comparator, inclusion of only depressed individuals and those willing to discuss their illness experience.
sions
individuals with BD appreciate the effects of medications, concerns regarding adverse effects and discrepancy between actual and hoped-for outcomes can be substantial. Subjective experience with medications using qualitative and quantitative methods should be explored in order to optimize treatment collaboration and outcomes.
Keywords
bipolar disorder , Subjective experience , mood stabilizer , Patient-centered treatment , Qualitative analysis
Journal title
Journal of Affective Disorders
Serial Year
2009
Journal title
Journal of Affective Disorders
Record number
1431753
Link To Document